Skip to main content
BIODESIX INC logo

BIODESIX INC — Investor Relations & Filings

Ticker · BDSX ISIN · US09075X1081 US Professional, scientific and technical activities
Open in API
Filings indexed 580 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country US United States of America
Listing US BDSX

About BIODESIX INC

https://www.biodesix.com/

Biodesix, Inc. is a life sciences diagnostics company focused on improving clinical outcomes, particularly in lung disease. The company develops and commercializes blood-based diagnostic tests that aid physicians in making treatment decisions and monitoring patient responses. Its product portfolio supports personalized care from early-stage disease detection to late-stage cancer therapy guidance. In addition to its diagnostic products, Biodesix provides biopharmaceutical services, offering its expertise and technologies to partners for diagnostic research, clinical trial support, and companion diagnostic development.

Recent filings

Filing Released Lang Actions
424B3
Regulatory Filings Classification · 80% confidence The document is a Securities and Exchange Commission prospectus filed pursuant to Rule 424(b)(3) registering shares of common stock for resale by existing stockholders. It is not an annual or quarterly report, earnings release, proxy, dividend notice, or any other narrowly defined category. It constitutes a regulatory filing (a registration statement/prospectus) that does not fit into specialized categories, so it falls under the fallback bucket “Regulatory Filings” (RNS).
2026-05-29 English
S-3
Share Issue/Capital Change Classification · 85% confidence The document is an SEC Form S-3 registration statement and prospectus for the resale of up to 375,000 shares of common stock by selling stockholders. This is not an earnings release, management discussion, audit report, or regulatory certification—rather it is a registration to facilitate a share offering (secondary sale). Under the provided taxonomy, this falls squarely under share issuance/capital changes (new share registration and sale).
2026-05-21 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 97% confidence The document is a Form 8-K reporting Item 5.07 – Submission of Matters to a Vote of Security Holders. It contains detailed voting results from the 2026 Annual Meeting of stockholders, including election of directors, advisory votes on executive compensation, vote frequency, and ratification of the independent auditor. This matches the definition for Declaration of Voting Results & Voting Rights Announcements.
2026-05-20 English
8-K - BIODESIX INC (0001439725) (Filer)
Regulatory Filings Classification · 90% confidence The document is a US SEC Form 8-K “Current Report” furnished pursuant to the Exchange Act, specifically reporting Item 2.02 (Results of Operations) with a press release attached as Exhibit 99.1. It is a regulatory compliance filing rather than a standalone earnings release, annual or interim report. Under the taxonomy, SEC Forms 8-K fall under the general Regulatory Filings category (RNS).
2026-05-04 English
ARS - BIODESIX INC (0001439725) (Filer)
Annual Report
2026-04-09 English
DEF 14A - BIODESIX INC (0001439725) (Filer)
Proxy Solicitation & Information Statement
2026-04-09 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.